Liquid Biopsy: Revolutionizing Ovarian Cancer Diagnosis And Treatment
Received Date: Oct 01, 2025 / Published Date: Oct 29, 2025
Abstract
Liquid biopsy, employing circulating tumor DNA (ctDNA) and other biomarkers in bodily fluids, presents a less invasive approach for ovarian cancer diagnosis, monitoring, and treatment selection. It aids in early detection, identifying minimal residual disease (MRD), and guiding therapy, with evolving applications. Challenges in standardization and sensitivity are being addressed through ongoing research, including the exploration of cfDNA methylation profiles and the integration of multiple biomarkers
Citation: Patel DE (2025) Liquid Biopsy: Revolutionizing Ovarian Cancer Diagnosis And Treatment. Current Trends Gynecol Oncol 10: 298.
Copyright: 漏 2025 Dr. Emily Patel This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 194
- [From(publication date): 0-0 - Apr 12, 2026]
- Breakdown by view type
- HTML page views: 142
- PDF downloads: 52
